Portal Industrial Cartagena Colombia - Forum - Contacts

The design and synthesis of novel psychoactive substances (NPS) have been a subject of interest for the scientific community, owing to their potential therapeutic applications and the need to understand their pharmacological properties better. Among the various NPS, the synthetic cannabinoid ADB-PINACA (methyl 2-[1-(5-fluoropentyl)-1H-indazol-3-yl]-1-methylpropyl-formate) has gained significant attention due to its unique chemical structure and pharmacological profile. This article aims to provide a comprehensive review of the synthesis, composition, production, and applications of ADB-PINACA.

Chemical Composition and Synthesis of ADB-PINACA

https://bbgate.com/media/adb-pinaca-synthesis.93/

ADB-PINACA is a synthetic cannabinoid receptor agonist, belonging to the class of indazole-based cannabinoids. The chemical structure of ADB-PINACA consists of a indazole ring, a pentyl chain, and a formyl group at the 3-position of the indazole ring, and a methyl 1-methylpropyl ester group at the 2-position of the indazole ring. The presence of the fluorine atom at the 5-position of the pentyl chain increases the lipophilicity and metabolic stability of the compound.

The synthesis of ADB-PINACA involves several steps, starting with the reaction of 5-fluoropentan-1-ol with 3-bromo-1-(bromomethyl)indazole in the presence of potassium carbonate to form the 5-fluoropentyl bromide derivative. The bromide derivative is then reacted with methyl 1-methylpropyl formate in the presence of potassium carbonate to form ADB-PINACA. The synthesis requires careful control of reaction conditions, such as temperature, reaction time, and solvent, to ensure high yield and purity of the final product.

Production of ADB-PINACA

The production of ADB-PINACA involves the large-scale synthesis of the compound, followed by purification and formulation into various dosage forms, such as powders, liquids, or crystals. The production of ADB-PINACA requires specialized knowledge and expertise in organic chemistry, as well as adherence to strict quality control measures to ensure the safety and efficacy of the final product.

The production of ADB-PINACA is subject to regulations and laws governing the manufacture and distribution of controlled substances. In many countries, the production of ADB-PINACA is strictly regulated, and only licensed manufacturers are allowed to produce and distribute the compound. The production of ADB-PINACA also requires compliance with good manufacturing practices (GMP) and other quality standards to ensure the safety and efficacy of the final product.

Applications of ADB-PINACA

ADB-PINACA has potential therapeutic applications due to its affinity for the cannabinoid receptor CB1, which is involved in various physiological processes, such as pain perception, appetite regulation, and memory. Preclinical studies have shown that ADB-PINACA has analgesic and anti-inflammatory effects, making it a potential candidate for the treatment of pain and inflammatory disorders.

However, the use of ADB-PINACA as a therapeutic agent is still in the early stages of research, and further studies are needed to evaluate its safety and efficacy in humans. The potential abuse and dependence liability of ADB-PINACA is also a concern, as the compound has been associated with cases of intoxication and addiction.

Conclusion

In conclusion, ADB-PINACA is a synthetic cannabinoid receptor agonist with a unique chemical structure and pharmacological profile. The synthesis, composition, production, and applications of ADB-PINACA are complex and require specialized knowledge and expertise. While ADB-PINACA has potential therapeutic applications, its abuse and dependence liability are concerns that need to be addressed. Further research is needed to evaluate the safety and efficacy of ADB-PINACA as a therapeutic agent and to develop strategies to prevent its misuse and abuse.